Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALBUPHINE vs NAPROXEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALBUPHINE vs NAPROXEN: Safety Overview

Metric NALBUPHINE NAPROXEN
Total FAERS Reports 702 52,751
Deaths Reported 78 5,127
Death Rate 11.1% 9.7%
Hospitalizations 95 12,849
Average Patient Age 42.1 yrs 55.0 yrs
% Female Patients 63.5% 71.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Henry Schein, Inc. Aurobindo Pharma Limited
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Discontinued